Read Summary

Risk for hepatocellular carcinoma (HCC) is lower for patients who have sustained viral responses after drug therapy for hepatitis C, but this treatment does not cure fibrosis, a common cause of HCC.
Medscape Medical News

Print Friendly, PDF & Email